Clincosm LogoSign in Get a demo

resectable pancreatic adenocarcinoma

Showing 1 - 11 of 11
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Resected Pancreatic and Ampullary Adenocarcinoma at Favorable

Enrolling by invitation
  • Resectable Pancreatic Adenocarcinoma
    • Milan, Italy
      National Cancer Institute of Milan
    Mar 3, 2023

    Pancreatic Acinar Cell Carcinoma, Pancreatic Adenosquamous Carcinoma, Pancreatic Squamous Cell Carcinoma Trial in United States

    Recruiting
    • Pancreatic Acinar Cell Carcinoma
    • +6 more
    • Biospecimen Collection
    • +4 more
    • Anchorage, Alaska
    • +357 more
    Jan 28, 2023

    Identify microRNAs in Cachexia in Pancreatic Carcinoma

    Recruiting
    • Resectable Pancreatic Adenocarcinoma
    • Pancreatic cancer microRNA and messenger RNA expression.
    • Oklahoma City, Oklahoma
      Stephenson Cancer Center
    Jan 9, 2023

    Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Resectable Pancreatic Adenocarcinoma Trial in Netherlands (Leucovorin

    Recruiting
    • Pancreatic Cancer
    • +2 more
    • Leucovorin Calcium
    • +4 more
    • 's-Hertogenbosch, Netherlands
    • +19 more
    Jan 6, 2023

    Borderline Resectable Pancreatic Adenocarcinoma, Resectable Pancreatic Adenocarcinoma, Stage IA Pancreatic Cancer AJCC v8 Trial

    Recruiting
    • Borderline Resectable Pancreatic Adenocarcinoma
    • +5 more
    • Durvalumab
    • +3 more
    • Houston, Texas
      M D Anderson Cancer Center
    Oct 12, 2022

    Pancreatic Adenosquamous Carcinoma, Resectable Pancreatic Adenocarcinoma, Pancreatic Cancer Trial in United States (drug,

    Recruiting
    • Pancreatic Adenosquamous Carcinoma
    • +2 more
    • Mobile, Alabama
    • +182 more
    Aug 1, 2022

    Resectable Pancreatic Adenocarcinoma Trial in Seoul (neoadjuvant modified FOLFIRINOX)

    Recruiting
    • Resectable Pancreatic Adenocarcinoma
    • neoadjuvant modified FOLFIRINOX
    • Seoul, Korea, Republic of
      Division of Medical Oncology, Yonsei Cancer Center, Yonsei Univ.
    Sep 23, 2021

    Resectable Pancreatic Adenocarcinoma, Borderline Resectable Pancreatic Adenocarcinoma Trial (Stereotactic Ablative Body

    Not yet recruiting
    • Resectable Pancreatic Adenocarcinoma
    • Borderline Resectable Pancreatic Adenocarcinoma
    • Stereotactic Ablative Body Radiotherapy (SABR)
    • (no location specified)
    Jun 16, 2021

    Resectable Pancreatic Adenocarcinoma Trial in Seoul (Intraoperative radiation therapy (IORT))

    Unknown status
    • Resectable Pancreatic Adenocarcinoma
    • Intraoperative radiation therapy (IORT)
    • Seoul, Korea, Republic of
      Gangnam Severance Hospital
    Feb 2, 2021

    Resectable Pancreatic Adenocarcinoma, Pancreatic Cancer Trial in Orange (GM-CSF)

    Completed
    • Resectable Pancreatic Adenocarcinoma
    • Pancreatic Cancer
    • GM-CSF
    • Orange, California
      Chao Family Comprehensive Cancer Center
    Jun 7, 2018

    Resectable Pancreatic Adenocarcinoma Trial in Ciudad Real (HIPEC-gemcitabine)

    Recruiting
    • Resectable Pancreatic Adenocarcinoma
    • Ciudad Real, Spain
      Hospital Universitario de Ciudad Real, HGUCR
    Aug 13, 2017